Published: 2017-07-20

Usage of blood products in emergency department at tertiary care centre

Ramesh Gorghatta Hanumanthaiah, Dheemantha Prasad, Panchakshari Prasanna Bangalore Krishnappa, Sreelatha R.


Background: Blood usage in the emergency department is a formidable challenge to the treating doctor. Inadvertent use of blood can do more harm to the patient than good. Analyzing blood transfusion data will help in formulating policies for transfusion in Emergency medicine department. The present study is taken to formulate guidelines for transfusion in Emergency department of our hospital. The present study also helps us to analyze the blood requirement, utilization and wastage in Emergency department, Victoria hospital.

Methods: The study done was a prospective study over a period of three months from March 2016 to May 2016. A descriptive, prospective study was conducted with a total of three hundred cases collected from the Emergency department (Casualty), Victoria hospital.

Results: Commonest indication for packed red cell transfusion was anemia, for FFP was hypoproteinaemia and for platelet concentrate was viral hemorrhagic fever. Transfusion trigger for packed red cells is haemoglobin of less than 7gram/dl with no co-morbid conditions and 7-9 gram/dl when there are co-morbid conditions.

Conclusions: A protocol has to be formulated to reduce the wastage and to effectively utilise blood and its products.


Blood products, Emergency department

Full Text:



Sahu S, Hemlata AV. Adverse events related to blood transfusion. Indian J anaesth. 2014;58(5):543.

Akanksha B, Surinder S, Marwaha N. Hemovigilance program-India. Asian J Transfus Sci. 2013;7(1):73-4.

Alcantara KSATY, Alresheid AA, Shammary SAMA. Comparative study on blood components utilization in selected hospital-blood banks in hail. IOSR J Nurs Health Sci. 2015;4(1):28-33.

Klein HG, Spahn DR, Carson JL. Red blood cell transfusion in clinical practice. Lancet. 2007;370(9585):415-26.

Gibson BES, Todd A, Roberts I, Pamphilon D, Rodeck C, Bolton-Maggs P et al. British Committee for standards in haematology transfusion task force. Brit J Haematol. 2004;124:433-53.

Sharma S, Sharma P, Tyler LN. Transfusion of blood and blood products: indications and complications. Am Fam Physician. 2011;83(6):719-24.

Sihler KC, Lena M. Napolitano MD. Complications of massive transfusion. Chest. 2010;137(1):209-220.

Yaddanapudi S, Yaddanapudi LN. Indications for blood and blood product transfusion. Indian J Anaesth. 2014;58(5):538-42.

Amarapurkar PD, Amarapurkar DN. Management of coagulopathy in patients with decompensated liver cirrhosis. Int J Hepatol. 2011:1-5.

Kaufman RM, Djulbegovic B, Gernsheimer T, Kleinman S, Tinmouth AT, Capocelli KE, et al. platelet transfusion: a clinical practice guideline from the AABB. Ann Intern Med. 2015;162(3):205-13.

Makroo RN, Raina V, Kumar P, Kanth RK. Role of platelet transfusion in the management of dengue patients in a tertiary care hospital. Asian J Transfus Sci. 2007;1(1): 4-7.

Yaddanapudi S, Yaddanapudi LN. Indication for blood and blood product transfusion. Indian J Anaesth. 2014;58(5):538-42.

Carson JL, Carless PA, Hebert PC. Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion. The Cochrane Library. 2012.